Sort
53,477 grants matching “addiction”
DAT-Emulating target trials with big data to strengthen the evidence base for the clinical management of opioid use disorder
$486,752Bohdan Nosyk · Simon Fraser University · R01 · FY2023 · DA
Novel Non-Peptide Opioid Ligands for Pain
$486,733Victor J Hruby · University Of Arizona · R01 · FY2012 · DA
Supporting data-driven decision-making to support substance use service expansion policies and to prevent overdoses
$486,685Gracelyn Cruden · Chestnut Health Systems, Inc. · R61 · FY2023 · DA
Cortical Biobehavioral Disruption after Thiamine Deficiency and Chronic Alcohol
$486,678Lisa M Savage · State University Of Ny,Binghamton · R01 · FY2015 · AA
Targeting AVIL in Glioblastoma
$486,645Hui Li · University Of Virginia · R01 · FY2022 · CA
Targeting AVIL in Glioblastoma
$486,645Hui Li · University Of Virginia · R01 · FY2023 · CA
Prefrontal mechanisms underlying polydrug heroin and alcohol use
$486,519Jamie L Peters · University Of Alabama At Birmingham · R01 · FY2025 · DA
UNC Neuroscience Center Research Cores
$486,400William D Snider · Univ Of North Carolina Chapel Hill · P30 · FY2015 · NS
UNC Neuroscience Center Research Cores
$486,400William D Snider · Univ Of North Carolina Chapel Hill · P30 · FY2016 · NS
UNC Neuroscience Center Research Cores
$486,400William D Snider · Univ Of North Carolina Chapel Hill · P30 · FY2014 · NS
UNC Neuroscience Center Research Cores
$486,400William D Snider · Univ Of North Carolina Chapel Hill · P30 · FY2017 · NS
Clinical Core
$486,377Henry Richard Kranzler · University Of Pennsylvania · P30 · FY2019 · DA
Administrative Core
$486,368Leslie Diane Leve · University Of Oregon · P50 · FY2019 · DA
Validation of a functional MRI-based reward processing task as a non-invasive too
$486,328Mary Louise Phillips · University Of Pittsburgh At Pittsburgh · RC1 · FY2009 · MH
New Inactivators of GABA Aminotransferase for Addiction and Epilepsy
$486,322Richard B Silverman · Northwestern University · R01 · FY2017 · DA
Missing Data Matters: Substance Use Disorder Clinical Trials
$486,320Daniel Oscar Scharfstein · Johns Hopkins University · R01 · FY2019 · DA
Evaluating Nicoting Lozenges for Treatment of Smokeless Tobacco Addiction
$486,307Jon O Ebbert · Mayo Clinic Rochester · R01 · FY2007 · CA
HIV Risk Reduction for Drug Dependent Black Men
$486,229University Of Michigan At Ann Arbor · R01 · FY2002 · DA
Training Program: Drugs of Abuse and Related Neuropeptides
$486,226Ellen M Unterwald · Temple Univ Of The Commonwealth · T32 · FY2013 · DA
Buprenorphine analogs for the treatment of opioid abuse
$486,210Mei-Chuan Ko · Wake Forest University Health Sciences · R01 · FY2023 · DA
Cholinergic regulation of striatal neurochemistry in cue-triggered decision-making
$486,180Sean Bjorn Ostlund · University Of California-Irvine · R01 · FY2018 · MH
Abuse liability of reduced nicotine content cigarettes within a complex tobacco marketplace
$486,138Warren K Bickel · Virginia Polytechnic Inst And St Univ · R01 · FY2018 · DA
Dopamine Transporter Cell Surface Dynamics
$486,135Haley E Melikian · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · DA
Functional Segregation Within the Whisker-Barrel Neuraxis
$486,117Mark F Jacquin · Washington University · R01 · FY2019 · NS
The role of familiarity neurocircuitry in novelty seeking
$486,113Andrew R Tapper · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · DA